Clinical Trial Update: Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating gemcitabine alone or with enzastaurin in advanced or metastatic pancreatic cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Neoplasm

Drugs mentioned

• Enzastaurin (enzastaurin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Pancreatic Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2020-08-31